Effect of fatty acids on renal ammoniagenesis in in vivo and in vitro studies. Am. J. Physiol.
23 l(3): 880-887. 1976. -Intravenous or renal intra-arterial infusion of sodium octanoate results in a 60% decrease in renal ammoniagenesis in the acidotic dog. Mobilization of endogenous fatty acids by levarterenol infusion is accompanied by a 30% fall in renal ammoniagenesis which coincides with considerable increase in renal extraction of fatty acids. In both types of experiments, the renal extraction of glutamine falls in proportion with decreased ammoniagenesis. The effect of octanoate and levarterenol infusion cannot be explained by changes in acid-base equilibrium, renal hemodynamics, or the release of insulin. In vitro experiments using kidney cortical slices from acidotic dogs show that addition of sodium octanoate (0.05-10 mM) or sodium palmitate (0.1-2.5 mM> to the incubation medium induces a 35% decrease in both ammonia and glucose production when L-glutamine (1 mM) is used as the basic ammoniagenic and gluconeogenic substrate. Glutamine uptake decreases concomitantly, whereas tissue glutamate either rises or remains unchanged. The same results were observed when L-glutamate (5 mM) was used as substrate. Glycerol (5 mM) in the medium has no effect on ammoniagenesis, whereas gluconeogenesis increases by 81%. The present studies demonstrate that fatty acids may interfere with renal ammoniagenesis from glutamine during acidosis. This effect is probably related to substrate availability and competition.
Fatty acids appear to inhibit ammoniagenesis in the mitochondria through a direct metabolic effect linked with their oxidation and not through modification of glutamine transport across the mitochondrial membrane.
levarterenol; renal gluconeogenesis; glycerol; insulin; L-glutamine; L-glutamate WE HAVE PREVIOUSLY DEMONSTRATED that infusion of exogenous ketone bodies markedly depresses renal ammoniagenesis during ammonium chloride-induced acidosis in both man and. dog (29, 43) . This effect could not be attributed to either urinary pH variations, systemic acid-base changes, or alterations in hemodynamics (29, 43 ). This constitutes a paradoxical observation in view of the well-established and striking increase in urinary ammonia excretion observed in man during starvation (37) and diabetic ketosis (35). In these situations where ketone bodies are endogenously produced, marked elevation in plasma free fatty acids (FFA) is a primary event (25). We are thus faced with clinicopathological states which are quite different from the experimental conditions under which our work was performed. Because fatty acids may be considered an important nutrient for the kidney (14, 21, 31 ,47),
we have undertaken to examine their possible effect on renal ammoniagenesis during both in vivo and in vitro experiments.
METHODS

In Vivo Studies
All in vivo experiments were performed on female mongrel dogs weighing between 13.6 and 27.7 kg and made acidotic with ammonium chloride. During the 4 days which preceded the experiments, each animal was given ammonium chloride (0.5 g/kg per day) mixed with soft commercial dog food. The animals were also fed dog Purina laboratory chow (Ralston Purina Co., St. Louis, MO.) and had free access to water. Food was restricted during 12 h before anesthesia but free water intake was allowed. The animals were anesthetized with sodium pentobarbital (30 mg/kg) and intubated. Respiration was controlled by a volume-and rate-adjustable respiration pump (Harvard Apparatus Co., Inc., Millis, Mass.) to maintain plasma Pco2 near 40 mmHg while the animals breathed room air. The left kidney was exposed through a midline abdominal incision. The left renal vein was catheterized through a femoral vein after ligation of the left ovarian vein. The position of the catheter was checked by palpation. The left ureter was catheterized and urine collected under mineral oil. Heparinized blood samples were drawn anaerobically from the femoral artery and the renal vein. Throughout each experiment, the animals were infused with isotonic sodium sulfate (Na,SO,) containing appropriate amounts of creatinine and para-aminohippurate (PAH). This solution was delivered to a femoral vein with a Bowman-type infusion pump at the rate of 5.6 ml/min. Octanoate, norepinephrine, and insulin were infused separately in a jugular vein or the left renal artery with a Buchler polystaltic pump (Buchler Instruments Div., NuclearChicago Corp., Fort Lee, N.J.). During the control period, 0.9% saline was infused through this route. After adequate and stable urine flow had been achieved, three lo-min collections of urine were taken as controls.
Octanoic acid (J. T. Baker Chemical Co., Philipsburg, N.J.) was infused into 11 animals. The sodium salt was prepared by mixing octanoic acid with saline and sodium hydroxide. A 0.16 M solution was infused at the rate of 1.5 mmol/kg over a l-h period. The pH of the octanoate solution was 7.20-7.30. Six animals were infused via the jugular vein and five in the left renal artery using a no. 25-G needle. At least six consecutive lo-min urinary collections were taken after the beginning of the octanoate infusion. In another group of five animals, crystalline insulin was added to 0.9% saline and infused in the left renal artery at the rate of 0.5 U/ min for 1 h. Finally, levarterenol bitartrate in 0.9% saline was administered through a jugular vein to five animals at the rate of 0.5 pg/kg per min for 1 h. In these experiments, blood pressure was monitored with a strain-gauge transducer (Statham Instruments Inc., Oxnard, Calif., model P-23Db).
Total ammonia production by the left kidney was estimated as the sum of ammonia added to the renal vein and that excreted in the urine per minute. The renal extraction of glutamine was taken as the product of arteriovenous plasma concentration difference and corrected renal plasma flow. The corrected PAH clearance was taken as the measure of effective renal plasma flow (RPF, >. Total renal blood flow (RBF, > was calculated using the corresponding hematocrit value. Citrate in systemic arterial and renal venous plasma was determined by the method of Beutler and Yeh (6). Free fatty acids in systemic arterial and renal venous plasma were measured on the AutoAnalyzer by the method of Antonis (2). Plasma glucose was determined by the glucose oxidase method (Glucostat, Worthington Biochemicals Corp., Freehold, N.J.) (22). All other analytical methods used in this study have been previously reported (28, 29) .
In Vitro Studies
Renal cortex slices from acidotic dogs were prepared according to a technique previously reported (8) and incubated with L-glutamine 1 mM or L-glutamate 5 mM at pH 7.0. Each flask contained 140-180 mg tissue in 10 ml Krebs-Henseleit bicarbonate solution gassed with 5% CO,-95% 0, with the following composition in millimoles per liter: sodium 144, potassium 4.7, calcium 2.5, magnesium 1.2, chloride 143, bicarbonate 10, and phosphate 1.2. The osmolarity was 297 mosM. The pH of the medium remained within 6.95-7.05 during incubation. Tissue glutamate was measured after homogenization of frozen slices according to a procedure already reported (8). The slices were incubated during 60 min in a Dubnoff metabolic shaker in 25-ml flasks at 37°C. Ammonia and glucose production and glutamine extraction were measured by methods previously reported (8). In 18 experiments performed on 18 acidotic dogs with a mean plasma bicarbonate of 13.7 mM, cortical slices were incubated with glutamine 1 mM or glutamate 5 mM with added sodium salt of octanoic acid at concentrations from 0.05 to 10 mM. Cortical slices from eight acidotic animals (plasma bicarbonate 15.2 mM) were incubated with added sodium salt of palmitic acid (J. T. Baker Chemicals Co.). Sodium palmitate was dissolved in a solution of fatty acid-free bovine serum albumin (Cohn fract ' ion V, Sigma Chemical Company, St. Louis, MO.) according to the technique of Soloni and Sardina (41). Fatty acid-free albumin was prepared according to the method of Chen (9). The albumin was dialyzed three consecutive times in a seamless cellulose tube against a 0.0075 M sodium phosphate solution at pH 7.4 in order to remove acetate and citrate from the albumin fraction. The dialyzed albumin was lyophilized and stored at 4°C until further use. The albumin thus prepared had no effect on was also ammonia or ascertained glucose that ne production by the sl ither octanoate nor ices. It palmitate interferes with the determination of ammonia, glucose, glutamine, or glutamate. The cortical slices were incubated with L-glutamine 1 mM and palmitate in concentrations ranging from 0 to 2.5 mM. In two experiments with palmitate, nr,-carnitine hydrochloride (Sigma) neutralized to pH 7.2 was added to the incubation mM.
medium in The effect concentrati of glycerol .ons ranging from 0.4 to 2 5 mM on ammoniagenesis and glucose production was studied on six occasions in slices from six acidotic animals with mean plasma bicarbonate of 15.4 mM.
Results are expressed as mean t standard error and were s tatistically compared paired or unpaired data.
by the Student t test for
RESULTS
In Vivo Experiments
Effect of octanoate. As shown in Fig. 1 , the systemic venous or renal arterial infusion of octanoate resulted in a striking decrease in ammonia production in the order of 50% after 30 min and 65% after 60 min. This decrement was secondary to decrease in both urinary ammonia excretion and renal vein ammonia release (Fig. 1 ). During these experiments, plasma bicarbonate or urinary pH did not vary significantly (Table 1) . Titratable acid excretion rose in a modest but insignificant fashion (Table 1) . Glutamine extraction (Table 1) fell by 60% at 30 min and 75% at 60 min. This remarkable change was not accompanied by a proportional drop in renal hemodynamics. The fall in renal plasma flow never exceeded 18%, whereas glomerular filtration remained unchanged (Table 1) . Renal extraction of PAH fell by 34% at 30 min and 49% at 60 min. Arterial plasma citrate concentration rose by 55 and 66% at 30 and 60 min. The uptake of citrate by the kidney remained positive, and no net release of citrate in the renal vein could be demonstrated during octanoate infusion (Table 1) . Arterial plasma glutamine concentration rose by less than 12% at 60 min (Table 1) . Mean blood glucose fell from 105 to 85 mg/lOO ml. Table 1 reports values obtained during the systemic vein infusion of octanoate. Results obtained during intrarenal arterial infusion were similar. In these experiments sodium excretion rose from 235 t 26 to 305 t 30 at 30 min and 354 2 31 ,ueq/min at 60 min, whereas potassium excretion remained constant at 32-37 peqlmin.
Effect of in&in. During the infusion of insulin in the left renal artery, plasma glucose fell from 108 to 52 mg/ 100 ml at 60 min (Fig. 2) . Total ammonia production remained unchanged, whereas both glomerular filtration rate and renal plasma flow (not shown) did not vary by more than 15% from control.
Effect of ZeuarterenoZ. As shown in Table 2 , the infusion of levarterenol resulted in a progressive elevation of free fatty acids from 0.39 to 1.44 pmollml at 30 min and 1.76 pmol/ml at 60 min. Total ammonia production did not change significantly during the first 30 min. However, at 60 min a mean fall of 26% was recorded with a decrease in both urinary excretion and renal vein release. Simultaneously, glutamine extraction fell by 21% (Table 2) . Glomerular filtration rate was remarkably stable throughout each experiment (Table 2 ). The renal plasma flow corrected for extraction of PAH fell by 16%, whereas total renal blood flow was not affected ( Table 2 ). The moderate decrease in renal plasma flow can be attributed to the well-known effect of levarterenol on plasma volume (17). Also, contraction of the dog spleen (17) explains the observed 18% rise in hematocrit and the lack of change of total renal blood flow. Mean arterial blood pressure did not change during infusion of levarterenol with values of 124 mmHg at 30 min and 120 mmHg at 60 min compared to control values of 117 mmHg. Urinary pH did not change during the first 30 (Table 2) . In these experiments, sodium excretion rose from 257 t 22 to 347 -+ 24 at 30 min, falling slightly to 313 t 20 peq/min at 60 min. Potassium excretion which was stable at 58 zeq/min during control and at 30 min fell to 46 at 60 min.
In Vitro Experiments
Effect of octanoate. Octanoate in the incubation medium in concentrations ranging from 0.05 to 5.0 mM induces a significant reduction in ammonia production (in the order of 35%) when L-glutamine 1 mM is used as ammoniagenic and gluconeogenic substrate (Table 3) . Glutamine uptake is reduced in a significant but less striking fashion. Glucose production from glutamine was also affected by octanoate decreasing by some 25%. It should be pointed out that a maximal effect for octanoate on both ammonia and glucose production is already obtained at 0.5 mM (Table 3) . Tissue glutamate rose significantly by 35% to decrease progressively thereafter and return near control values as octanoate was increased to 5 mM (Table 3) . No significant effect on ammonia or glucose production by octanoate could be detected, and tissue glutamate remained unchanged when no glutamine was present in the medium. Table 4 FATTY ACIDS AND AMMONIAGENESIS
shows that a similar effect of 0.5 mM octanoate is seen when 5 mM L-glutamate are used as an ammoniagenic and gluconeogenic substrate.
The concentration of glutamate used here was 5 mM because of the low rates of glucose and ammonia production observed with dog slices at the 1 mM level. The time course of ammonia and glucose production, glutamine uptake, and total glutamate release is presented in Fig. 3 . It is apparent that glucose and ammonia production as well as glutamine uptake are linearly related to time for the whole 60-min period. In the presence of added octanoate (0.5 mM), all three processes are depressed but show the same relationship with time. In the absence of glutamine, although ammonia and glucose production rose slowly with time, the observed values remained low. It should be noted that glutamate release was significantly enhanced by the addition of octanoate to glutamine and reached a maximal value after 45 min of incubation.
Effect of palmitate. Palmitate, dissolved in fatty acidfree albumin, induced a significant reduction in ammo- (Table 5) . Tissue glutamate measured in four experiments did not change significantly. In the two experiments where DL-carnitine was added to the incubation medium, the results were the same.
Effect of glyceroZ. Glycerol at 5 mM in the medium had no effect whatsoever on ammonia production. Its striking gluconeogenic action was demonstrated with 81% increase in glucose production (Table 6 ). Glutamine uptake, tissue glutamate concentration, and glutamate release in the medium were unchanged after addition of glycerol. The data also demonstrate that the gluconeogenie activity of glycerol is clearly additive to that of glutamine (Table 6 ).
DISCUSSION
The present study demonstrates that short-and longchain fatty acids depress renal ammoniagenesis both in vivo and in vitro in the acidotic dog. In addition, we have shown that octanoate and palmitate also depress gluconeogenesis from L-glutamine in vitro. The marked depression in renal ammoniagenesis induced by octanoate infusion in the intact acidotic dog is reminiscent of that described previously with infusion of ketone bodies nia production reaching 30% at 0.5 mM concentration (Table 5) . No further effect was observed at higher concentrations.
Glutamine uptake also decreased but less strikingly.
Glucose production decreased concomitantlv with ammonia by as much as 57% at 0.5 mM glutamine and glycerol + glutamine. 
acid-base status. The concomitant depression of renal extraction of glutamine accounts entirely for the observed decrease in ammoniagenesis. Failure of glutamine to reach the renal tubular cell (28) cannot be invoked, since arterial plasma glutamine concentration did not change, glomerular filtration remained constant, and renal plasma flow and blood flow fell only slightly during octanoate infusion. As a matter of fact, the load of glutamine delivered to the kidney during infusion of octanoate did not decrease by more than 13%, whereas glutamine extraction fell by 74% and ammonia production by 66%. Thus, octanoate exerts its inhibitory action at the level of the renal tubular cell. Reabsorption of filtered glutamine was not modified by octanoate because no glutamine was detected in the urine. An action of octanoate on glutamine uptake at the antiluminal site cannot be excluded, although this is unlikely in view of the magnitude of its effect. If glutamine gains access to the cell interior, it could be prevented from crossing the mitochondrial barrier. On the other hand, the mitochondrial metabolism of glutamine could be inhibited by the metabolism of octanoate per se. In any event, there is no doubt that octanoate prevented utilization of glutamine within the cell because filtered and reabsorbed glutamine at 60 min was 19 PM per min whereas extraction had fallen to 7.8 PM per min. Thus, at least 11 ,uM per min of reabsorbed glutamine (58%) could not be utilized for ammonia production after reaching the cell interior.
In the present study,' octanoate exerted its wellknown depressing effect on PAH transport, the renal extraction of PAH decreasing by 49%. This effect has been well demonstrated both in vitro (10,31) and in vivo (45). It is assumed that octanoate anion competes with PAH for the tubular organic acid transport system (10, 45). Since PAH is transported and secreted in the proximal tubule and since amino acids including L-glutamine are also transported in the proximal tubule (30, 48), the possible relationship between octanoate, PAH, and glutamine extraction by the kidney must be raised. However, we are aware of no evidence suggesting that PAH interferes with the renal extraction-of glutamine and ammoniagenesis.
It administration of insulin with a 50% decrease in blood glucose concentration had no effect whatsoever on renal ammoniagenesis. It is noteworthy that endogenous elevation of plasma free fatty acids during levarterenol infusion resulted in a significant decrease in renal ammonia production in the acidotic dog. The 4.5fold increase in plasma FFA during levarterenol infusion is comparable to that reported by others (11, 19, 24) . The depression in renal ammoniagenesis was concomitant with a threefold increase in renal free fatty acids uptake and was grossly proportional to the simultaneous fall in the renal extraction of glutamine.
During these experiments, there was no change in extracellular acid-base status or urinary pH to explain the observed changes in ammoniagenesis. In fact, urinary pH became slightly more acid, a condition that should favor ammonia excretion. In these studies, renal plasma flow fell by 16% but renal blood flow did not vary by more than 6%. The fall in plasma flow is readily explained by the contracting effect of epinephrine and norepinephrine on plasma volume (17). In the dog, this effect is counterbalanced by the release of erythrocytes from contraction of the spleen (17), which was regularly observed during our experiments.
Thus, whereas renal plasma flow decreased, the circulating erythrocyte volume increased so that total renal blood flow remained unchanged. We sis when the rat slices were incubated with glutamine glutamine and palmitate at near physiological concenand palmitate at concentrations similar to that used in tration in the incubation medium [l mM for glutamine the present study. We have no explanation for this (8, 28, 29) and 0.6 mM for palmitate (ll)], the described difference with the exception that the latter experichanges occur, suggesting that physiological metaboments were performed in nonacidotic rats instead of lism of palmitate by the renal cortex depresses that of acidotic dogs. However, we see no reason why fatty glutamine.
It is well known that both octanoate and acids should have an effect opposite to that of ketone palmitate may be utilized by the renal tissue both in bodies which are known to depress ammoniagenesis in iivo (4, 5, 11, 14, 21, 33, 45) and in vitro (13, 20, 26, 27 , the dog both in vivo (29) and in vitro (unpublished data).
47)
we have already alluded to the possibility that fatty
We have previously suggested that the marked elevation in plasma free fatty acids which takes place during acids could interfere with the uptake of glutamine by starvation and uncontrolled diabetes mellitus could the renal tubular cell. In this respect, our in vitro play a role in stimulating ammoniagenesis, thus counstudies with L-glutamate provide an argument against terbalancing the depressing effect of ketone bodies (29). such a mechanism.
The elevation of tissue glutamate or This concept was subsequently also invoked by Roxe et glutamate release in vitro when octanoate is added to al. (38). The present study fails to support such a possiflasks in the presence of L-glutamine could be taken as bility because fatty acids have the same depressing evidence for a primary decrease in glutamate utilization effect on ammoniagenesis as do ketone bodies. by the kidney tubular cells. Since glutamate is an inhibitor of mitochondrial transport of glutamine (15) 
